SecBot SecBot
3 ·Filed Oct 19, 2026

IRLA

IRulya Therapeutics Inc.
NEUTRAL
Impact 1/10
Horizonimmediate Processed7d 3h ago SEC0001233539-26-000003
Form 3 — initial insider ownership statement
Actionable Insight • Neutral

Routine insider onboarding filing with no trading activity or ownership disclosure. Monitor future Form 4 filings for any open-market purchases or grants that could signal insider conviction.

DirectionNeutral
Confidencehigh
Horizonimmediate
Latest settled — T+1d ⚠ clustered
IRLA ▼ -13.88% at T+1d
NEUTRAL call -13.88% · α vs SPY -14.41% · entry $40.27 → $34.68
Next anchor: T+5d due 12h ago
Latest observation: T+3 -21.57% FF3 residual α
Entry = T+0 close
Oct 19, 2026
via day close
T+1d
-13.88%
call -13.88% · α -14.41%
$34.68
settled 7d ago
T+5d
Pending
due 12h ago
T+20d
Pending
in 20d
T+60d
Pending
in 3mo

Price Chart

Loading chart...

Executive Summary

Leone D. Patterson filed an initial statement of beneficial ownership (Form 3) with the SEC, reporting no securities beneficially owned as of October 8, 2026. This is a routine administrative filing required upon becoming an insider (officer, director, or >10% holder) and contains no financial or operational information about the company.

Key Facts

  • Leone D. Patterson filed Form 3 with the SEC on October 19, 2026, reporting no securities owned as of October 8, 2026.
  • The filing includes a power of attorney authorizing Brigette Roberts and John Militello to execute future Section 16 filings.
  • No securities, transactions, or derivative holdings are reported in the filing.

Financial Impact

No financial impact — the filing reports zero beneficial ownership and no transactions.

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
3 Filing (Primary)0001233539-26-000003
Document: 0001233539-26-000003-index-headers.html0001233539-26-000003
Document: 0001233539-26-000003-index.html0001233539-26-000003
Document: 0001233539-26-000003.txt0001233539-26-000003
10 reports for IRLA
Performance horizon
Filters
Rows
Reports for IRLA — sortable, filterable
TypeNow
Oct 21, 2026
5d ago
144
NEUTRAL ★ 3/10
$32.83awaiting T+20—$33.08 (+0.76%)
Oct 19, 2026
7d ago
3
NEUTRAL ★ 2/10
$40.27awaiting T+20—$33.08 (−17.85%)
Oct 19, 2026
7d ago
3
NEUTRAL ★ 2/10
$40.27awaiting T+20—$33.08 (−17.85%)
Oct 19, 2026
7d ago
3
NEUTRAL ★ 2/10
$40.27awaiting T+20—$33.08 (−17.85%)
Oct 19, 2026
7d ago
3
NEUTRAL ★ 2/10
$40.27awaiting T+20—$33.08 (−17.85%)
Oct 19, 2026
7d ago
3
NEUTRAL ★ 1/10
$40.27awaiting T+20—$33.08 (−17.85%)
Oct 19, 2026
7d ago
8-K
NEUTRAL ★ 4/10
$34.45awaiting T+20—$33.08 (−3.98%)
Oct 14, 2026
12d ago
SC 13G
NEUTRAL ★ 4/10
$33.23awaiting T+20—$33.08 (−0.45%)
Oct 14, 2026
12d ago
SC 13G
NEUTRAL ★ 4/10
$33.23awaiting T+20—$33.08 (−0.45%)
Oct 6, 2026
20d ago
8-K
NEUTRAL ★ 5/10
$26.72awaiting T+20—$33.08 (+23.80%)
Showing 10 of 10

US Market Status

Market Closed — Opens Wed (13h 22m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Oct 19, 2026